BioRationality: FDA Removes Additional Testing for Interchangeable Status of Biosimilars

Formycon receives FDA approval for FYB203/Ahzantive®) (aflibercept-mrbb), a biosimilar to Eylea®). News release. Formycon. July 1, 2024. Accessed …